Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Urologic Neoplasms × VMBP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1 Carcinoma, Renal Cell 1

Interventions

valrubicin 1 niraparib 1 cabozantinib 1 atezolizumab 1 Zoledronic Acid 1 VMBP protocol 1 Trastuzumab 1 Sunitinib 1 Standard of Care 1 Nivolumab 1 Etoposide 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300140 2023-10-30

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Aravive, Inc.

Phase 1/2 Terminated

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡